{"url_path":"/sec/pcrx/8-k/2026-06-30/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1396814/0001628280-26-046136-index.html","accession_number":"0001628280-26-046136","cik":"0001396814","ticker":"PCRX","issuer_name":"Pacira BioSciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1396814/0001628280-26-046136-index.html","primary_entity_key":"0001396814","primary_entity_name":"Pacira BioSciences, Inc."},"word_count":111,"has_tables":true,"body_markdown":"Item 7.01. Regulation FD Disclosure.\n\nOn June 30, 2026, the Company issued a press release announcing that it had entered into the Purchase Agreement, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8‑K.\n\nThe information contained in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing."}